866-997-4948(US-Canada Toll Free)

United States Recombinant Peptides Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

In this report, the United States Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Peptides in these regions, from 2012 to 2022 (forecast).

United States Recombinant Peptides market competition by top manufacturers/players, with Recombinant Peptides sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Glucagon
Calcitonin
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Recombinant Peptides for each application, including
Insulin
Human Growth Hormone
Blood Products
Other

Table of Contents

United States Recombinant Peptides Market Report 2017
1 Recombinant Peptides Overview
1.1 Product Overview and Scope of Recombinant Peptides
1.2 Classification of Recombinant Peptides by Product Category
1.2.1 United States Recombinant Peptides Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Recombinant Peptides Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Glucagon
1.2.4 Calcitonin
1.2.5 Other
1.3 United States Recombinant Peptides Market by Application/End Users
1.3.1 United States Recombinant Peptides Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Insulin
1.3.3 Human Growth Hormone
1.3.4 Blood Products
1.3.5 Other
1.4 United States Recombinant Peptides Market by Region
1.4.1 United States Recombinant Peptides Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Recombinant Peptides Status and Prospect (2012-2022)
1.4.3 Southwest Recombinant Peptides Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Recombinant Peptides Status and Prospect (2012-2022)
1.4.5 New England Recombinant Peptides Status and Prospect (2012-2022)
1.4.6 The South Recombinant Peptides Status and Prospect (2012-2022)
1.4.7 The Midwest Recombinant Peptides Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Recombinant Peptides (2012-2022)
1.5.1 United States Recombinant Peptides Sales and Growth Rate (2012-2022)
1.5.2 United States Recombinant Peptides Revenue and Growth Rate (2012-2022)

2 United States Recombinant Peptides Market Competition by Players/Suppliers
2.1 United States Recombinant Peptides Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Recombinant Peptides Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Recombinant Peptides Average Price by Players/Suppliers (2012-2017)
2.4 United States Recombinant Peptides Market Competitive Situation and Trends
2.4.1 United States Recombinant Peptides Market Concentration Rate
2.4.2 United States Recombinant Peptides Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Peptides Manufacturing Base Distribution, Sales Area, Product Type

3 United States Recombinant Peptides Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Recombinant Peptides Sales and Market Share by Region (2012-2017)
3.2 United States Recombinant Peptides Revenue and Market Share by Region (2012-2017)
3.3 United States Recombinant Peptides Price by Region (2012-2017)

4 United States Recombinant Peptides Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Recombinant Peptides Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Recombinant Peptides Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Peptides Price by Type (2012-2017)
4.4 United States Recombinant Peptides Sales Growth Rate by Type (2012-2017)

5 United States Recombinant Peptides Sales (Volume) by Application (2012-2017)
5.1 United States Recombinant Peptides Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Peptides Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Recombinant Peptides Players/Suppliers Profiles and Sales Data
6.1 Sandoz Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Recombinant Peptides Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sandoz Pharma Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Stada Arzneimittel
6.2.2 Recombinant Peptides Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Stada Arzneimittel Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Amgen
6.3.2 Recombinant Peptides Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Amgen Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Hospira
6.4.2 Recombinant Peptides Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Hospira Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Actavis
6.5.2 Recombinant Peptides Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Actavis Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Cipla Ltd.
6.6.2 Recombinant Peptides Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Cipla Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Wockhardt Ltd.
6.7.2 Recombinant Peptides Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Wockhardt Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Biocon Ltd.
6.8.2 Recombinant Peptides Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Biocon Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Recombinant Peptides Manufacturing Cost Analysis
7.1 Recombinant Peptides Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Peptides

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Recombinant Peptides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Peptides Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Recombinant Peptides Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Recombinant Peptides Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Recombinant Peptides Sales Volume Forecast by Type (2017-2022)
11.3 United States Recombinant Peptides Sales Volume Forecast by Application (2017-2022)
11.4 United States Recombinant Peptides Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Recombinant Peptides
Figure United States Recombinant Peptides Market Size (K MT) by Type (2012-2022)
Figure United States Recombinant Peptides Sales Volume Market Share by Type (Product Category) in 2016
Figure Glucagon Product Picture
Figure Calcitonin Product Picture
Figure Other Product Picture
Figure United States Recombinant Peptides Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Recombinant Peptides by Application in 2016
Figure Insulin Examples
Figure Human Growth Hormone Examples
Figure Blood Products Examples
Figure Other Examples
Figure United States Recombinant Peptides Market Size (Million USD) by Region (2012-2022)
Figure The West Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Peptides Sales (K MT) and Growth Rate (2012-2022)
Figure United States Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Peptides Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Recombinant Peptides Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Recombinant Peptides Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Peptides Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Peptides Sales Share by Players/Suppliers
Figure United States Recombinant Peptides Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Recombinant Peptides Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Recombinant Peptides Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Peptides Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Peptides Revenue Share by Players/Suppliers
Table United States Market Recombinant Peptides Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Recombinant Peptides Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Recombinant Peptides Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Peptides Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Peptides Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Peptides Product Category
Table United States Recombinant Peptides Sales (K MT) by Region (2012-2017)
Table United States Recombinant Peptides Sales Share by Region (2012-2017)
Figure United States Recombinant Peptides Sales Share by Region (2012-2017)
Figure United States Recombinant Peptides Sales Market Share by Region in 2016
Table United States Recombinant Peptides Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Recombinant Peptides Revenue Share by Region (2012-2017)
Figure United States Recombinant Peptides Revenue Market Share by Region (2012-2017)
Figure United States Recombinant Peptides Revenue Market Share by Region in 2016
Table United States Recombinant Peptides Price (USD/MT) by Region (2012-2017)
Table United States Recombinant Peptides Sales (K MT) by Type (2012-2017)
Table United States Recombinant Peptides Sales Share by Type (2012-2017)
Figure United States Recombinant Peptides Sales Share by Type (2012-2017)
Figure United States Recombinant Peptides Sales Market Share by Type in 2016
Table United States Recombinant Peptides Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Recombinant Peptides Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Peptides by Type (2012-2017)
Figure Revenue Market Share of Recombinant Peptides by Type in 2016
Table United States Recombinant Peptides Price (USD/MT) by Types (2012-2017)
Figure United States Recombinant Peptides Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Peptides Sales (K MT) by Application (2012-2017)
Table United States Recombinant Peptides Sales Market Share by Application (2012-2017)
Figure United States Recombinant Peptides Sales Market Share by Application (2012-2017)
Figure United States Recombinant Peptides Sales Market Share by Application in 2016
Table United States Recombinant Peptides Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Peptides Sales Growth Rate by Application (2012-2017)
Table Sandoz Pharma Basic Information List
Table Sandoz Pharma Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz Pharma Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Sandoz Pharma Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Sandoz Pharma Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Stada Arzneimittel Basic Information List
Table Stada Arzneimittel Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Amgen Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Amgen Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Hospira Basic Information List
Table Hospira Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hospira Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Hospira Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Hospira Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Actavis Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Actavis Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Actavis Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Cipla Ltd. Basic Information List
Table Cipla Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cipla Ltd. Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Cipla Ltd. Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Cipla Ltd. Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Wockhardt Ltd. Basic Information List
Table Wockhardt Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Biocon Ltd. Basic Information List
Table Biocon Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Ltd. Recombinant Peptides Sales Growth Rate (2012-2017)
Figure Biocon Ltd. Recombinant Peptides Sales Market Share in United States (2012-2017)
Figure Biocon Ltd. Recombinant Peptides Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Peptides
Figure Manufacturing Process Analysis of Recombinant Peptides
Figure Recombinant Peptides Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Peptides Major Players/Suppliers in 2016
Table Major Buyers of Recombinant Peptides
Table Distributors/Traders List
Figure United States Recombinant Peptides Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Peptides Price (USD/MT) Trend Forecast (2017-2022)
Table United States Recombinant Peptides Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Recombinant Peptides Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Recombinant Peptides Sales Volume (K MT) Forecast by Type in 2022
Table United States Recombinant Peptides Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Recombinant Peptides Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Recombinant Peptides Sales Volume (K MT) Forecast by Application in 2022
Table United States Recombinant Peptides Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Recombinant Peptides Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Peptides Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Peptides Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *